Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alhavi Pharmaceutical is a prominent Iranian pharmaceutical manufacturer established in 1968, originally operating as a subsidiary of the American firm Parke-Davis. The company specializes in the production of a wide range of generic medicines, over-the-counter (OTC) drugs, and nutritional supplements. Its extensive product portfolio covers critical therapeutic areas such as cardiovascular health, gastroenterology, the central nervous system, and internal medicine. Alhavi operates state-of-the-art manufacturing facilities in Tehran that comply with international Good Manufacturing Practice (GMP) standards. As a subsidiary of the Tamin Pharmaceutical Investment Company (TPICO), it plays a vital role in the Iranian healthcare sector and exports products to various regional markets. The company is publicly traded on the Tehran Stock Exchange and continues to expand its reach through the development of new generic formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alhavi Pharmaceutical.